- Joined
- May 16, 2023
- Messages
- 32,794
- Points
- 113
Singapore doctors develop new cell therapy that saved patients from treatment-resistant cancer
Sixteen patients went into complete remission within a month of the treatment. They previously had a less than 10 per cent chance of survival as the cancer did not respond to chemotherapy and other treatments.
Listen to this article
7 min
This audio is generated by an AI tool.

Michael Yong
05 Oct 2024 06:00AM (Updated: 05 Oct 2024 08:12AM)
BookmarkShare
SINGAPORE: A team of doctors in Singapore has developed a new cell therapy for cancer patients who have otherwise exhausted all other forms of treatment.
For these patients with T-cell acute lymphoblastic leukaemia (T-ALL) that do not respond to chemotherapy or relapse after treatment, the prognosis is normally bad – they have a less than 10 per cent chance of survival.
However, 16 patients who underwent this experimental treatment went into complete remission within a month.
The new cell therapy was developed by researchers and clinicians from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS) and the National University Health System (NUHS).
The treatment has now been published in the medical journal Nature Medicine.